| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study.
|
Lancet
|
2012
|
12.10
|
|
2
|
Reversal of rivaroxaban and dabigatran by prothrombin complex concentrate: a randomized, placebo-controlled, crossover study in healthy subjects.
|
Circulation
|
2011
|
6.47
|
|
3
|
Idarucizumab for Dabigatran Reversal.
|
N Engl J Med
|
2015
|
5.91
|
|
4
|
Effectiveness of managing suspected pulmonary embolism using an algorithm combining clinical probability, D-dimer testing, and computed tomography.
|
JAMA
|
2006
|
4.75
|
|
5
|
Cardiovascular risk factors and venous thromboembolism: a meta-analysis.
|
Circulation
|
2007
|
3.20
|
|
6
|
Performance of 4 clinical decision rules in the diagnostic management of acute pulmonary embolism: a prospective cohort study.
|
Ann Intern Med
|
2011
|
2.28
|
|
7
|
Risk of deep vein thrombosis and pulmonary embolism in asthma.
|
Eur Respir J
|
2012
|
2.08
|
|
8
|
Potential of an age adjusted D-dimer cut-off value to improve the exclusion of pulmonary embolism in older patients: a retrospective analysis of three large cohorts.
|
BMJ
|
2010
|
1.99
|
|
9
|
Statin treatment and the risk of recurrent pulmonary embolism.
|
Eur Heart J
|
2013
|
1.58
|
|
10
|
Cardiovascular risk assessment in haemophilia patients.
|
Thromb Haemost
|
2010
|
1.57
|
|
11
|
Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients.
|
Intern Emerg Med
|
2008
|
1.54
|
|
12
|
Safety and feasibility of a diagnostic algorithm combining clinical probability, d-dimer testing, and ultrasonography for suspected upper extremity deep venous thrombosis: a prospective management study.
|
Ann Intern Med
|
2014
|
1.42
|
|
13
|
Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatran.
|
Thromb Haemost
|
2015
|
1.36
|
|
14
|
Association of V617F Jak2 mutation with the risk of thrombosis among patients with essential thrombocythaemia or idiopathic myelofibrosis: a systematic review.
|
Thromb Res
|
2009
|
1.17
|
|
15
|
Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel.
|
Am J Obstet Gynecol
|
2009
|
1.08
|
|
16
|
Statins, fibrates, and venous thromboembolism: a meta-analysis.
|
Eur Heart J
|
2009
|
1.08
|
|
17
|
Incidental venous thromboembolism in cancer patients: prevalence and consequence.
|
Thromb Res
|
2010
|
1.04
|
|
18
|
Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.
|
Thromb Haemost
|
2012
|
1.04
|
|
19
|
Using an age-dependent D-dimer cut-off value increases the number of older patients in whom deep vein thrombosis can be safely excluded.
|
Haematologica
|
2012
|
1.00
|
|
20
|
Skin autofluorescence as a measure of advanced glycation end products deposition is elevated in peripheral artery disease.
|
Arterioscler Thromb Vasc Biol
|
2012
|
0.99
|
|
21
|
Acute pulmonary embolism. Part 2: treatment.
|
Nat Rev Cardiol
|
2010
|
0.96
|
|
22
|
Skin autofluorescence is associated with 5-year mortality and cardiovascular events in patients with peripheral artery disease.
|
Arterioscler Thromb Vasc Biol
|
2014
|
0.95
|
|
23
|
Quality of life after pulmonary embolism as assessed with SF-36 and PEmb-QoL.
|
Thromb Res
|
2013
|
0.95
|
|
24
|
The factor VIII/von Willebrand factor ratio discriminates between reduced synthesis and increased clearance of von Willebrand factor.
|
Thromb Haemost
|
2002
|
0.92
|
|
25
|
Multidetector CT scan for acute pulmonary embolism: embolic burden and clinical outcome.
|
Chest
|
2012
|
0.91
|
|
26
|
Established and new-generation antithrombotic drugs in patients with cirrhosis - possibilities and caveats.
|
J Hepatol
|
2013
|
0.90
|
|
27
|
Lack of association between common genetic variation in endothelial lipase (LIPG) and the risk for CAD and DVT.
|
Atherosclerosis
|
2010
|
0.90
|
|
28
|
Edoxaban for treatment of venous thromboembolism in patients with cancer. Rationale and design of the Hokusai VTE-cancer study.
|
Thromb Haemost
|
2015
|
0.89
|
|
29
|
Long-term cardiovascular mortality in patients with differentiated thyroid carcinoma: an observational study.
|
J Clin Oncol
|
2013
|
0.86
|
|
30
|
Acute pulmonary embolism. Part 1: epidemiology and diagnosis.
|
Nat Rev Cardiol
|
2010
|
0.85
|
|
31
|
Diagnostic strategy using a modified clinical decision rule and D-dimer test to rule out pulmonary embolism in elderly in- and outpatients.
|
Thromb Haemost
|
2005
|
0.84
|
|
32
|
Clinical decision rule and D-dimer have lower clinical utility to exclude pulmonary embolism in cancer patients. Explanations and potential ameliorations.
|
Thromb Haemost
|
2010
|
0.84
|
|
33
|
Impact of delay in clinical presentation on the diagnostic management and prognosis of patients with suspected pulmonary embolism.
|
Am J Respir Crit Care Med
|
2013
|
0.83
|
|
34
|
Search for HRV-parameters that detect a sympathetic shift in heart failure patients on β-blocker treatment.
|
Front Physiol
|
2013
|
0.83
|
|
35
|
Pulmonary embolism, myocardial infarction, and ischemic stroke in lung cancer patients: results from a longitudinal study.
|
Lung
|
2013
|
0.82
|
|
36
|
CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients.
|
BMC Cancer
|
2013
|
0.82
|
|
37
|
Improved myocardial perfusion preceding clinical response on bosentan treatment for coronary vasospasm.
|
Acta Cardiol
|
2009
|
0.81
|
|
38
|
Time-trends in treatment and cardiovascular events in patients with heart failure: a pharmacosurveillance study.
|
Eur J Heart Fail
|
2010
|
0.81
|
|
39
|
Management strategies for optimal control of anticoagulation in patients with atrial fibrillation.
|
Semin Thromb Hemost
|
2009
|
0.80
|
|
40
|
β2-adrenergic receptor genotype influences the effect of nonselective vs. selective β-blockade on baroreflex function in chronic heart failure.
|
Int J Cardiol
|
2011
|
0.79
|
|
41
|
Coronary artery calcification in hemophilia A: no evidence for a protective effect of factor VIII deficiency on atherosclerosis.
|
Arterioscler Thromb Vasc Biol
|
2011
|
0.79
|
|
42
|
Venous thromboembolism prophylaxis and treatment in patients with acute stroke and traumatic brain injury.
|
Curr Opin Crit Care
|
2008
|
0.78
|
|
43
|
Venous thrombosis at unusual sites and the role of thrombophilia.
|
Semin Thromb Hemost
|
2007
|
0.78
|
|
44
|
Systolic heart failure: a prothrombotic state.
|
Semin Thromb Hemost
|
2009
|
0.78
|
|
45
|
New anticoagulants: moving on from scientific results to clinical implementation.
|
Ann Med
|
2011
|
0.77
|
|
46
|
Incidence of postpartum haemorrhage in women receiving therapeutic doses of low-molecular-weight heparin: results of a retrospective cohort study.
|
BMJ Open
|
2011
|
0.77
|
|
47
|
Wells Rule and d-Dimer Testing to Rule Out Pulmonary Embolism: A Systematic Review and Individual-Patient Data Meta-analysis.
|
Ann Intern Med
|
2016
|
0.77
|
|
48
|
Clot lysis phenotype and response to recombinant factor VIIa in plasma of haemophilia A inhibitor patients.
|
Br J Haematol
|
2013
|
0.77
|
|
49
|
Clinical impact of findings supporting an alternative diagnosis on CT pulmonary angiography in patients with suspected pulmonary embolism.
|
Chest
|
2013
|
0.77
|
|
50
|
Comparison of 4- and 64-slice CT scanning in the diagnosis of pulmonary embolism.
|
Thromb Haemost
|
2009
|
0.76
|
|
51
|
A low molecular weight heparin inhibits experimental metastasis in mice independently of the endothelial glycocalyx.
|
PLoS One
|
2010
|
0.76
|
|
52
|
Thrombolysis for pulmonary embolism and venous thrombosis: is it worthwhile?
|
Semin Thromb Hemost
|
2007
|
0.76
|
|
53
|
Inhibitors of factor VIII in hemophilia.
|
N Engl J Med
|
2009
|
0.76
|
|
54
|
Control of life-threatening pulmonary bleeding with activated recombinant factor VII.
|
Am J Med
|
2002
|
0.76
|
|
55
|
Thrombogenicity in patients with percutaneous coronary artery intervention and dual antiplatelet treatment.
|
Eur Heart J
|
2008
|
0.75
|
|
56
|
Defining the role of computed tomographic pulmonary angiography in suspected pulmonary embolism.
|
Ann Intern Med
|
2005
|
0.75
|
|
57
|
Effect of Linagliptin on Arterial (18)F-Fluorodeoxyglucose Positron Emission Tomography Uptake: A Randomized Controlled Trial (RELEASE).
|
J Am Coll Cardiol
|
2017
|
0.75
|
|
58
|
Myocardial infarction, ischaemic stroke and pulmonary embolism before and after breast cancer hospitalisation. A population-based study.
|
Thromb Haemost
|
2011
|
0.75
|
|
59
|
[Exclusion of deep-vein thrombosis and pulmonary embolism using clinical decision rules and D-dimer tests].
|
Ned Tijdschr Geneeskd
|
2010
|
0.75
|
|
60
|
Differential effects of nonselective versus selective β-blockers on cardiac sympathetic activity and hemostasis in patients with heart failure.
|
J Nucl Med
|
2013
|
0.75
|
|
61
|
Coagulation factors--molecular attributes and their clinical impact.
|
Thromb Res
|
2008
|
0.75
|
|
62
|
Brief Report: Association Between Statin Use and Cardiovascular Mortality at the Population Level: An Ecologic Study.
|
Epidemiology
|
2015
|
0.75
|
|
63
|
Optimization of the diagnostic management of clinically suspected pulmonary embolism in hospitalized patients.
|
Br J Haematol
|
2014
|
0.75
|
|
64
|
Is a normal computed tomography pulmonary angiography safe to rule out acute pulmonary embolism in patients with a likely clinical probability? A patient-level meta-analysis.
|
Thromb Haemost
|
2017
|
0.75
|
|
65
|
Non-selective vs. selective beta-blocker treatment and the risk of thrombo-embolic events in patients with heart failure.
|
Eur J Heart Fail
|
2010
|
0.75
|